Phys Act Nutr Search

CLOSE


Phys Act Nutr > Volume 25(2); 2021 > Article
Physical Activity and Nutrition 2021;25(2):1-7.
DOI: https://doi.org/10.20463/pan.2021.0008    Published online June 30, 2021.
Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review
Bok Sil Hong1,2, Myoung-Ryu Kim2
1Life Science Research Center, Cheju Halla University, Jeju, Republic of Korea
2Department of Nursing, Cheju Halla University, Jeju, Republic of Korea
Correspondence:  Bok Sil Hong, Tel: +82-64-741-7653, Fax: +82-64-741-3989, 
Email: bshong@chu.ac.kr
Received: 4 June 2021   • Revised: 22 June 2021   • Accepted: 24 June 2021
Abstract
[Purpose]
Recent studies have shown that COVID-19 is often associated with altered gut microbiota composition and reflects disease severity. Furthermore, various reports suggest that the interaction between COVID-19 and host-microbiota homeostasis is mediated through the modulation of microRNAs (miRNAs). Thus, in this review, we aim to summarize the association between human microbiota and miRNAs in COVID-19 pathogenesis.
[Methods]
We searched for the existing literature using the keywords such “COVID-19 or microbiota,” “microbiota or microRNA,” and “COVID-19 or probiotics” in PubMed until March 31, 2021. Subsequently, we thoroughly reviewed the articles related to microbiota and miRNAs in COVID-19 to generate a comprehensive picture depicting the association between human microbiota and microRNAs in the pathogenesis of COVID-19.
[Results]
There exists strong experimental evidence suggesting that the composition and diversity of human microbiota are altered in COVID-19 patients, implicating a bidirectional association between the respiratory and gastrointestinal tracts. In addition, SARS-CoV-2 encoded miRNAs and host cellular microRNAs modulated by human microbiota can interfere with viral replication and regulate host gene expression involved in the initiation and progression of COVID-19. These findings suggest that the manipulation of human microbiota with probiotics may play a significant role against SARS-CoV-2 infection by enhancing the host immune system and lowering the inflammatory status.
[Conclusion]
The human microbiota-miRNA axis can be used as a therapeutic approach for COVID-19. Hence, further studies are needed to investigate the exact molecular mechanisms underlying the regulation of miRNA expression in human microbiota and how these miRNA profiles mediate viral infection through host-microbe interactions.
Key Words: SARS-CoV-2, COVID-19, human microbiota, dysbiosis, gut-lung axis, microRNAs
TOOLS
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 0 Crossref
  •     Scopus
  • 132 View
  • 9 Download
Related articles in Phys Act Nutr


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
Korea University, 145 Anam-Ro, Seongbuk-gu,Seoul 02841, Republic of Korea
Tel: +82-10-2235-0018    Fax: +82-2-3290-2315    E-mail: jenbedit@gmail.com                

Copyright © 2021 by Korean Society for Exercise Nutrition.

Developed in M2PI

Close layer
prev next